Natural compounds for oxidative stress and neuroprotection in schizophrenia: composition, mechanisms, and therapeutic potential

References

• Mitra S, Natarajan R, Ziedonis D, Fan X. Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2017;78:1–11. doi:10.1016/j.pnpbp.2017.05.005.
   PubMed Web of Science ®Google Scholar
• Kane JM, Correll CU. Pharmacologic treatment of schizophrenia. Dialog Clin Neurosci. 2010;12(3):345–57.
   PubMedGoogle Scholar
• Girdler SJ, Confino JE, Woesner ME. Exercise as a treatment for schizophrenia: a review. Psychopharmacol Bull. 2019;49(1):56. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386427/.
   PubMedGoogle Scholar
• Madireddy S, Madireddy S. Regulation of reactive oxygen species-mediated damage in the pathogenesis of schizophrenia. Brain Sci. 2020;10(10):742.
   PubMed Web of Science ®Google Scholar
• Murray AJ, Rogers JC, Katshu MZUH, Liddle PF, Upthegrove R. Oxidative stress and the pathophysiology and symptom profile of schizophrenia spectrum disorders. Front Psychiatry. 2021. doi:10.3389/fpsyt.2021.703452.
   Web of Science ®Google Scholar
• Hardingham GE. NMDA receptor C-terminal signaling in development, plasticity, and disease. F1000 Res. 2019: 8. doi:10.12688/f1000research.19925.1.
   PubMedGoogle Scholar
• Fang X, Chen Y, Wang Y, Ren J, Zhang C. Depressive symptoms in schizophrenia patients: a possible relationship between SIRT1 and BDNF. Prog Neuropsychopharmacol Biol Psychiatry. 2019. doi:10.1016/j.pnpbp.2019.109673.
   Web of Science ®Google Scholar
• Hardingham GE, Do KQ. Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis. Nat Rev Neurosci. 2016;17(2):125–34. doi:10.1038/nrn.2015.19.
   PubMed Web of Science ®Google Scholar
• Di Carlo P, Punzi G, Ursini G. BDNF and schizophrenia. Psychiatr Genet. 2019;29(5):200. doi:10.1097/YPG.0000000000000237.
   PubMedGoogle Scholar
• Miranda M, Morici JF, Zanoni MB, Bekinschtein P. Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci. 2019: 363. doi:10.3389/fncel.2019.00363.
   PubMed Web of Science ®Google Scholar
• Shnayder NA, Khasanova AK, Strelnik AI, Al-Zamil M, Otmakhov AP, Neznanov NG, et al. Cytokine imbalance as a biomarker of treatment-resistant schizophrenia. Int J Mol Sci. 2022;23(19):11324. doi:10.3390/ijms231911324.
   PubMed Web of Science ®Google Scholar
• Upthegrove R, Khandaker GM. Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia. Curr Top Behav Neurosci. 2020: 49–66. doi:10.1007/7854_2018_88.
   PubMedGoogle Scholar
• Trovão N, Prata J, VonDoellinger O, Santos S, Barbosa M, Coelho R. Peripheral biomarkers for first-episode psychosis—opportunities from the neuroinflammatory hypothesis of schizophrenia. Psychiatry Investig. 2019;16(3):177. doi:10.30773/pi.2018.12.19.1.
   PubMed Web of Science ®Google Scholar
• Li H-c, Chen Q-z, Ma Y, Zhou J-f. Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study. J Zhejiang Univ Sci B. 2006;7:981–6. doi:10.1631/jzus.2006.B0981.
   PubMedGoogle Scholar
• Virit O, Altindag A, Yumru M, Dalkilic A, Savas HA, Selek S, et al. A defect in the antioxidant defense system in schizophrenia. Neuropsychobiology. 2009;60(2):87–93. doi:10.1159/000239684.
   PubMed Web of Science ®Google Scholar
• Ojagbemi A, Gureje OJ. Perinatal depression in low-income women: a literature review and innovative screening approach. Curr Psychiatry Reports. 2020;22:1–7. doi:10.1007/s11920-019-1126-9.
   PubMed Web of Science ®Google Scholar
• Saleem A, Akhtar MF. Alternative therapy of psychosis: potential phytochemicals and drug targets in the management of schizophrenia. Front Pharmacol. 2022;13:895668. doi:10.3389/fphar.2022.895668.
   PubMed Web of Science ®Google Scholar
• Solberg DK, Refsum H, Andreassen OA, Bentsen H. A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia. Acta Neuropsychiatr. 2019;31(4):202–12.
   PubMed Web of Science ®Google Scholar
• Albayrak Y, Ünsal C, Beyazyüz M, Ünal A, Kuloğlu M. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45:144–9. doi:10.1016/j.pnpbp.2013.04.020.
   PubMed Web of Science ®Google Scholar
• Oshodi TO, Ben-Azu B, Ishola IO, Ajayi AM, Emokpae O, Umukoro S. Molecular mechanisms involved in the prevention and reversal of ketamine-induced schizophrenia-like behavior by rutin: the role of glutamic acid decarboxylase isoform-67, cholinergic, Nox-2-oxidative stress pathways in mice. Mol Biol Rep. 2021;48:2335–50. doi:10.1007/s11033-021-06264-6.
   PubMed Web of Science ®Google Scholar
• Ueno H, Shimada A, Suemitsu S, Murakami S, Kitamura N, Wani K, Matsumoto Y, et al. Attenuation effects of alpha-pinene inhalation on mice with dizocilpine-induced psychiatric-like behaviour. Evid Based Complement Alternat Med. 2019. doi:10.1155/2F2019/2F2745453.
   PubMed Web of Science ®Google Scholar
• Karanikas E, Daskalakis NP, Agorastos A. Oxidative dysregulation in early life stress and posttraumatic stress disorder: a comprehensive review. Brain Sci. 2021;11(6):723. doi:10.3390/brainsci11060723.
   PubMed Web of Science ®Google Scholar
• Cuenod M, Steullet P, Cabungcal J-H, Dwir D, Khadimallah I, Klauser P, et al. Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia. Mol Psychiatry. 2022;27(4):1886–97. doi:10.1038/s41380-021-01374-w.
   PubMed Web of Science ®Google Scholar
• Kumar V, Vajawat B, Rao NP. Frontal GABA in schizophrenia: a meta-analysis of 1H-MRS studies. World J Biol Psychiatry. 2021;22(1):1–13. doi:10.1080/15622975.2020.1731925.
   PubMed Web of Science ®Google Scholar
• Jiménez-Fernández S, Gurpegui M, Garrote-Rojas D, Gutiérrez-Rojas L, Carretero MD, Correll CU. Oxidative stress parameters and antioxidants in adults with unipolar or bipolar depression versus healthy controls: systematic review and meta-analysis. J Affect Disord. 2022. doi:10.1016/j.jad.2022.07.015.
   PubMedGoogle Scholar
• Adraoui FW, Douw L, Martens GJ, Maas DA. Connecting neurobiological features with interregional dysconnectivity in social-cognitive impairments of schizophrenia. Int J Mol Sci. 2023;24(9):7680. doi:10.3390/ijms24097680.
   PubMed Web of Science ®Google Scholar
• Sauce R, Pinto CASO, Ayala-Jara C, Prieto ZA, Velasco MVR, Baby AR. Preliminary protocol development of a hplc-tbars-evsc (Ex vivo stratum corneum) assay for skin research: application in a sunscreen system. Sci Pharm. 2021;89(2):17. https://www.mdpi.com/2218-0532/89/2/17.
   Web of Science ®Google Scholar
• Halstead S, Siskind D, Amft M, Wagner E, Yakimov V, Shih-Jung Liu Z, et al. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry. 2023. doi:10.1016/S2215-0366(23)00025-1.
   PubMed Web of Science ®Google Scholar
• Momtazmanesh S, Zare-Shahabadi A, Rezaei N. Cytokine alterations in schizophrenia: an updated review. Front Psychiatry. 2019;10:892. doi:10.3389/fpsyt.2019.00892.
   PubMed Web of Science ®Google Scholar
• Ait Tayeb AEK, Poinsignon V, Chappell K, Bouligand J, Becquemont L, Verstuyft C. Major depressive disorder and oxidative stress: a review of peripheral and genetic biomarkers according to clinical characteristics and disease stages. Antioxidants (Basel). 2023;12(4):942. doi:10.3390/antiox12040942.
   PubMedGoogle Scholar
• Ben-Azu B, Aderibigbe AO, Ajayi AM, Iwalewa EO. Neuroprotective effects of the ethanol stem bark extracts of Terminalia ivorensis in ketamine-induced schizophrenia-like behaviors and oxidative damage in mice. Pharm Biol. 2016;54(12):2871–9.
   PubMed Web of Science ®Google Scholar
• Patel K, Patel DK. The beneficial role of rutin, a naturally occurring flavonoid in health promotion and disease prevention: a systematic review and update. In: Bioactive food as dietary interventions for arthritis and related inflammatory diseases. 2019. p. 457–79. .doi:10.1016/B978-0-12-813820-5.00026-X.
   Google Scholar
• Białoń M, Wąsik A. Advantages and limitations of animal schizophrenia models. Int J Mol Sci. 2022;23(11):5968. doi:10.3390/ijms23115968.
   PubMed Web of Science ®Google Scholar
• Hatziagapiou K, Kakouri E, Lambrou GI, Bethanis K, Tarantilis PA. Antioxidant properties of Crocus sativus L. and its constituents and relevance to neurodegenerative diseases; focus on Alzheimer’s and Parkinson’s disease. Curr Neuropharmacol. 2019;17(4):377–402. doi:10.2174/1570159X16666180321095705.
   PubMed Web of Science ®Google Scholar
• D’Onofrio G, Nabavi SM, Sancarlo D, Greco A, Pieretti S. Crocus sativus L. (Saffron) in Alzheimer’s disease treatment: bioactive effects on cognitive impairment. Curr Neuropharmacol. 2021;19(9):1606. doi:10.2174/1570159X19666210113144703.
   PubMed Web of Science ®Google Scholar
• Pitsikas N. Crocus sativus L. extracts and its constituents crocins and safranal; potential candidates for schizophrenia treatment? Molecules. 2021;26(5):1237. doi:10.3390/molecules26051237.
   PubMed Web of Science ®Google Scholar
• Sun X-j, Zhao X, Xie J-n, Wan H. Crocin alleviates schizophrenia-like symptoms in rats by upregulating silent information regulator-1 and brain derived neurotrophic factor. Compr Psychiatry. 2020;103:152209.
   PubMed Web of Science ®Google Scholar
• Rajput SA, Wang X-q, Yan H-C. Morin hydrate: a comprehensive review on novel natural dietary bioactive compound with versatile biological and pharmacological potential. Biomed Pharmacother. 2021;138:111511. doi:10.1016/j.biopha.2021.111511.
   PubMed Web of Science ®Google Scholar
• Ben-Azu B, Aderibigbe AO, Ajayi AM, Eneni A-EO, Omogbiya IA, Owoeye O, et al. Morin decreases cortical pyramidal neuron degeneration via inhibition of neuroinflammation in mouse model of schizophrenia. Int Immunopharmacol. 2019;70:338–53. doi:10.1016/j.intimp.2019.02.052.
   PubMed Web of Science ®Google Scholar
• Kocot J, Luchowska-Kocot D, Kiełczykowska M, Musik I, Kurzepa J. Does vitamin C influence neurodegenerative diseases and psychiatric disorders? Nutrients. 2017;9(7):659. doi:10.3390/nu9070659.
   PubMed Web of Science ®Google Scholar
• Brown HE, Roffman JL. Vitamin supplementation in the treatment of schizophrenia. CNS Drugs. 2014;28:611–22. doi:10.1007/s40263-014-0172-4.
   PubMed Web of Science ®Google Scholar
• Bentsen H, Osnes K, Refsum H, Solberg DK, Bøhmer T. A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+ C in schizophrenia. Transl Psychiatry. 2013;3(12):e335–e335.
   PubMedGoogle Scholar
• Rizvi S, Raza ST, Ahmed F, Ahmad A, Abbas S, Mahdi F. The role of vitamin E in human health and some diseases. Sultan Qaboos Univ Med J. 2014;14(2):e157.
   PubMedGoogle Scholar
• Chambial S, Dwivedi S, Shukla KK, John PJ, Sharma P. Vitamin C in disease prevention and cure: an overview. Indian J Clin Biochem. 2013;28:314–28. doi:10.1007/s12291-013-0375-3.
   PubMedGoogle Scholar
• Campas-Baypoli ON, Bueno-Solano C, Martínez-Ibarra DM, Camacho-Gil F, Villa-Lerma AG, Rodríguez-Núñez JR, et al. Sulforaphane (1-isothiocyanato-4-(methylsulfinyl)-butane) content in cruciferous vegetables. Arch Latinoam Nutr. 2009;59(1):95–100. https://pubmed.ncbi.nlm.nih.gov/19480351/.
   PubMed Web of Science ®Google Scholar
• Kaar SJ, Angelescu I, Marques TR, Howes OD. Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies. J Neural Transm (Vienna). 2019;126:1637–51. doi:10.1007/s00702-019-02080-2.
   PubMed Web of Science ®Google Scholar
• Matsuura A, Ishima T, Fujita Y, Iwayama Y, Hasegawa S, Kawahara-Miki R, et al. Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation. Sci Rep. 2018;8(1):2158. doi:10.1038/s41598-018-20538-3.
   PubMedGoogle Scholar
• Fahey JW, Holtzclaw WD, Wehage SL, Wade KL, Stephenson KK, Talalay P. Sulforaphane bioavailability from glucoraphanin-rich broccoli: control by active endogenous myrosinase. PLoS One. 2015;10(11):e0140963. doi:10.1371/journal.pone.0140963.
   PubMed Web of Science ®Google Scholar
• Hei G, Smith RC, Li R, Ou J, Song X, Zheng Y, et al. Sulforaphane effects on cognition and symptoms in first and early episode schizophrenia: a randomized double-blind trial. Schizophrenia Bull Open. 2022;3(1):sgac024. doi:10.1093/schizbullopen/sgac024.
   Google Scholar
• Chang C-W, Lee J-J, Lu K-T. The effects of adding heartwood extractives from Acacia confusa on the lightfastness improvement of refined oriental lacquer. Polymers (Basel). 2021;13(23):4085. doi:10.3390/polym13234085.
   PubMed Web of Science ®Google Scholar
• Lin H-Y, Chang T-C, Chang S-T. A review of antioxidant and pharmacological properties of phenolic compounds in Acacia confusa. J Tradit Complement Med. 2018;8(4):443–50. doi:10.1016/j.jtcme.2018.05.002.
   PubMedGoogle Scholar
• Abrahams S, Haylett WL, Johnson G, Carr JA, Bardien S. Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: a review. Neuroscience. 2019;406:1–21. doi:10.1016/j.neuroscience.2019.02.020.
   PubMed Web of Science ®Google Scholar
• Zheng D, Huang C, Huang H, Zhao Y, Khan MRU, Zhao H, Huang L. Antibacterial mechanism of curcumin: a review. Chem Biodivers. 2020;17(8):e2000171. doi:10.1002/cbdv.202000171.
   PubMed Web of Science ®Google Scholar
• Moghaddam AH, Maboudi K, Bavaghar B, Sangdehi SRM, Zare M. Neuroprotective effects of curcumin-loaded nanophytosome on ketamine-induced schizophrenia-like behaviors and oxidative damage in male mice. Neurosci Lett. 2021;765:136249. doi:10.1016/j.neulet.2021.136249.
   PubMed Web of Science ®Google Scholar
• Thangaleela S, Sivamaruthi BS, Kesika P, Bharathi M, Kunaviktikul W, Klunklin A, et al. Essential oils, phytoncides, aromachology, and aromatherapy—a review. Appl Sci. 2022;12(9):4495. doi:10.3390/app12094495.
   Google Scholar
• Li H, Xia N, Hasselwander S, Diaber A. Resveratrol and vascular function. Int J Mol Sci. 2019;20(9):2155. doi:10.3390/ijms20092155.
   PubMed Web of Science ®Google Scholar
• Shayganfard M. Molecular and biological functions of resveratrol in psychiatric disorders: a review of recent evidence. Cell Biosci. 2020;10:1–14. doi:10.1186/s13578-020-00491-3.
   PubMed Web of Science ®Google Scholar
• Niu J, Cao Y, Ji Y. Resveratrol, a SIRT1 activator, ameliorates MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia. Front Psychiatry. 2020;11:716. doi:10.3389/fpsyt.2020.00716.
   PubMed Web of Science ®Google Scholar
• Akosman MS, Türkmen R, Demirel HH. Investigation of the protective effect of resveratrol in an MK-801-induced mouse model of schizophrenia. Environ Sci Pollut Res Int. 2021;28(46):65872–84. doi:10.1007/s11356-021-15664-x.
   PubMed Web of Science ®Google Scholar
• Zahrani NAA, El-Shishtawy RM, Asiri AM. Recent developments of gallic acid derivatives and their hybrids in medicinal chemistry: a review. Eur J Med Chem. 2020;204:112609. doi:10.1016/j.ejmech.2020.112609.
   PubMed Web of Science ®Google Scholar
• Mahindrakar KV, Rathod VK. Ultrasonic assisted aqueous extraction of catechin and gallic acid from Syzygium cumini seed kernel and evaluation of total phenolic, flavonoid contents and antioxidant activity. Antioxidants. 2020;149:107841. doi:10.3390/antiox9040352.
   Google Scholar
• Schimites P, Segat H, Teixeira L, Martins LR, Mangini LT, Baccin PS, et al. Gallic acid prevents ketamine-induced oxidative damages in brain regions and liver of rats. Neurosci Lett. 2020;714:134560. doi:10.1016/j.neulet.2019.134560.
   PubMed Web of Science ®Google Scholar
• Fidan H, Stankov S, Petkova N, Petkova Z, Iliev A, Stoyanova M, et al. Evaluation of chemical composition, antioxidant potential and functional properties of carob (Ceratonia siliqua L.) seeds. J Food Sci Technol. 2020;57:2404–13. doi:10.1007/s13197-020-04274-z.
   PubMed Web of Science ®Google Scholar
• Kyriacou MC, Antoniou C, Rouphael Y, Graziani G, Kyratzis A. Mapping the primary and secondary metabolomes of carob (Ceratonia siliqua L.) fruit and its postharvest antioxidant potential at critical stages of ripening. Antioxidants. 2021;10(1):57. doi:10.3390/antiox10010057.
   Web of Science ®Google Scholar
• Lakkab I, Ouakil A, El Hajaji H, Lachkar N, Lefter R, Ciobica A, et al. Carob seed peels effect on cognitive impairment and oxidative stress status in methionine-induced mice models of schizophrenia. Brain Sci. 2022;12(12):1660. doi:10.3390/brainsci12121660.
   PubMed Web of Science ®Google Scholar
• Lim YP, Pang SF, Yusoff MM, Abdul Mudalip SK, Gimbun J. Correlation between the extraction yield of mangiferin to the antioxidant activity, total phenolic and total flavonoid content of Phaleria macrocarpa fruits. J Appl Res Med. 2019;14:100224. doi:10.1016/j.jarmap.2019.100224.
   Google Scholar
• Al-Saeedi FJ. Mangiferin protect oxidative stress against deoxynivalenol induced damages through Nrf2 signalling pathways in endothelial cells. Clin Exp Pharmacol Physiol. 2021;48(3):389–400. doi:10.1111/1440-1681.13432.
   PubMed Web of Science ®Google Scholar
• Rao VS, Carvalho AC, Trevisan MTS, Andrade GM, Nobre HV, Moraes MO, et al. Mangiferin ameliorates 6-hydroxydopamineinduced cytotoxicity and oxidative stress in ketamine model of schizophrenia. Pharmacol Rep. 2012;64(4):848–56. doi:10.1016/s1734-1140(12)70879-4.
   PubMed Web of Science ®Google Scholar
• Lum PT, Sekar M, Gan SH, Pandy V, Bonam SR. Protective effect of mangiferin on memory impairment: a systematic review. Saudi J Biol Sci. 2021;28(1):917–27. doi:10.1016/j.sjbs.2020.11.037.
   PubMed Web of Science ®Google Scholar
• Rahman M. Plant diversity in Hazarikhil Wildlife Sanctuary of Chittagong and its conservation management. Environ Sci. 2018;3(2):43–56. doi:10.3329/JBCBM.V3I2.36027.
   Google Scholar
• Bristy TA, Barua N, Montakim Tareq A, Sakib SA, Etu ST, Chowdhury KH, et al. Deciphering the pharmacological properties of methanol extract of Psychotria calocarpa leaves by in vivo, in vitro and in silico approaches. Pharmaceuticals. 2020;13(8):183. doi:10.3390/ph13080183.
   Web of Science ®Google Scholar
• Fajemiroye JO, da Silva DM, de Oliveira DR, Costa EA. Treatment of anxiety and depression: medicinal plants in retrospect. Fundam Clin Pharmacol. 2016;30(3):198–215. doi:10.1111/fcp.12186.
   PubMed Web of Science ®Google Scholar
• Koval’Skii I, Krasnyuk I, Krasnyuk I, Nikulina OI, Belyatskaya AV, Kharitonov YY, et al. Mechanisms of rutin pharmacological action. Pharm Chem J. 2014;48:73–6. doi:10.1007/s11094-014-1050-6.
   Web of Science ®Google Scholar
• Mottaghi S, Abbaszadeh H. The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: current status, challenges, and future perspectives. Phytother Res. 2021;35(12):6843–61. doi:10.1002/ptr.7270.
   PubMed Web of Science ®Google Scholar
• Issac PK, Guru A, Velayutham M, Pachaiappan R, Arasu MV, Al-Dhabi NA, et al. Oxidative stress induced antioxidant and neurotoxicity demonstrated in vivo zebrafish embryo or larval model and their normalization due to morin showing therapeutic implications. Life Sci. 2021;283:119864. doi:10.1016/j.lfs.2021.119864.
   PubMed Web of Science ®Google Scholar
• Singh MP, Sharma C, Kang SC. Morin hydrate attenuates adenine-induced renal fibrosis via targeting cathepsin D signaling. Int Immunopharmacol. 2021;90:107234. doi:10.1016/j.intimp.2020.107234.
   PubMed Web of Science ®Google Scholar
• Singh A, Kukreti R, Saso L, Kukreti S. Oxidative stress: a key modulator in neurodegenerative diseases. Molecules. 2019;24(8):1583. doi:10.3390/molecules24081583.
   PubMed Web of Science ®Google Scholar
• Memarzia A, Khazdair MR, Behrouz S, Gholamnezhad Z, Jafarnezhad M, Saadat S, Boskabady MH. Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review. Biofactors. 2021;47(3):311–50. doi:10.1002/biof.1716.
   PubMed Web of Science ®Google Scholar
• Tomeh MA, Hadianamrei R, Zhao X. A review of curcumin and its derivatives as anticancer agents. Int J Mol Sci. 2019;20(5):1033. doi:10.3390/ijms20051033.
   PubMed Web of Science ®Google Scholar
• Cheng CK, Luo JY, Lau CW, Chen Z, Tian XY, Huang Y. Pharmacological basis and new insights of resveratrol action in the cardiovascular system. Br J Pharmacol. 2020;177(6):1258–77. doi:10.1111/bph.14801.
   PubMed Web of Science ®Google Scholar
• Baba SP, Bhatnagar A. Role of thiols in oxidative stress. Curr Opin Toxicol. 2018;7:133–9. doi:10.1016/j.cotox.2018.03.005.
   PubMedGoogle Scholar
• Ong WY, Farooqui T, Ho CFY, Farooqui AA. Use of phytochemicals against neuroinflammation. Neuroprot Effects Phytochem Neurol Disorders. 2017: 1–41. doi:10.1002/9781119155195.ch1.
   Google Scholar